Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001415889-24-028094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-11-29 | ANAB | RENTON HOLLINGS | Dir | M - OptEx | $6.93 | +10.0K | 11.9K | +513% | +$69.3K |
| D | 2024-12-03 | 2024-11-29 | ANAB | RENTON HOLLINGS | Dir | S - Sale+OE | $25.00 | -10.0K | 1,950 | -84% | -$250.0K |
| D | 2024-12-03 | 2024-11-29 | ANAB | RENTON HOLLINGS | Dir | M - OptEx | $0.00 | -10.0K | 20.9K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | M | A | 10,000 | $6.93 | 11,950 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-29 | S | D | 10,000 | $25.00 | 1,950 | D | — | — | |
| 3 | Derivative | Common Stock | 2024-11-29 | M | D | 10,000 | $0.00 | 20,925 | D | $6.93 · — to 2025-07-05 | 10,000 Common Stock | (F3) In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 95,541 shares of common stock, which options vest according to their terms. (F2) The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025. |